Published on 10 Nov 2023 on Zacks via Yahoo Finance

Is a Surprise Coming for Pliant Therapeutics (PLRX) This Earnings Season?

Investors are always looking for stocks that are poised to beat at earnings season and Pliant Therapeutics, Inc. PLRX, may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because Pliant Therapeutics is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for PLRX in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 74 cents per share for PLRX, compared to a broader Zacks Consensus Estimate of a loss of 78 cents per share. This suggests that analysts have very recently bumped up their estimates for PLRX, giving the stock a Zacks Earnings ESP of +4.72% heading into earnings season.